Search research articles
Contact Us
Filters
Showing results (81-90 of 115) with videos related to
Page
of 12
Sort By:
Medical Microbiology and Immunology
|
December 17, 2009
Tumor cells infected with oncolytic influenza A virus prime natural killer cells for lysis of resistant tumor cells
Henry Ogbomo, Martin Michaelis, Janina Geiler, et al.
Neoplasia (New York, N.Y.)
|
February 22, 2005
Multimutated herpes simplex virus g207 is a potent inhibitor of angiogenesis
Jindrich Cinatl, Martin Michaelis, Pablo Hernáiz Driever, et al.
International Journal of Oncology
|
January 5, 2006
Anti-cancer effects of bortezomib against chemoresistant neuroblastoma cell lines in vitro and in vivo
Martin Michaelis, Iduna Fichtner, Diana Behrens, et al.
Medical Microbiology and Immunology
|
April 14, 2010
Glycyrrhizin inhibits highly pathogenic H5N1 influenza A virus-induced pro-inflammatory cytokine and chemokine expression in human macrophages
Martin Michaelis, Janina Geiler, Patrizia Naczk, et al.
Journal of Medicinal Chemistry
|
February 3, 2006
Design and synthesis of dipeptidyl glutaminyl fluoromethyl ketones as potent severe acute respiratory syndrome coronovirus (SARS-CoV) inhibitors
Han-Zhong Zhang, Hong Zhang, William Kemnitzer, et al.
Journal of Clinical Microbiology
|
September 15, 2007
Novel approach for genotyping varicella-zoster virus strains from Germany
Jonas Schmidt-Chanasit, Martin Stürmer, Anke Hahn, et al.
Medical Microbiology and Immunology
|
September 19, 2003
Thrombin induces Sp1-mediated antiviral effects in cytomegalovirus-infected human retinal pigment epithelial cells
Martin Scholz, Jens-Uwe Vogel, Gerold Höver, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
June 30, 2009
Measurements of HCV neutralizing antibodies and of HCV-specific CD4+ and CD8+ cells using hepatitis C virus pseudo-particles (HCVpp)
Annemarie Berger, Tsanan Giroglou, Anke Leutz, et al.
Cancer Research
|
January 17, 2009
Reversal of P-glycoprotein-mediated multidrug resistance by the murine double minute 2 antagonist nutlin-3
Martin Michaelis, Florian Rothweiler, Denise Klassert, et al.
Sexually Transmitted Diseases
|
June 10, 2010
Prevalence- and gender-specific immune response to opportunistic infections in HIV-infected patients in Lesotho
Holger F Rabenau, Tessa Lennemann, Claudia Kircher, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 115) with videos related to
Sort By:
Page
of 12
Medical Microbiology and Immunology
|
December 17, 2009
Tumor cells infected with oncolytic influenza A virus prime natural killer cells for lysis of resistant tumor cells
Henry Ogbomo, Martin Michaelis, Janina Geiler, et al.
Neoplasia (New York, N.Y.)
|
February 22, 2005
Multimutated herpes simplex virus g207 is a potent inhibitor of angiogenesis
Jindrich Cinatl, Martin Michaelis, Pablo Hernáiz Driever, et al.
International Journal of Oncology
|
January 5, 2006
Anti-cancer effects of bortezomib against chemoresistant neuroblastoma cell lines in vitro and in vivo
Martin Michaelis, Iduna Fichtner, Diana Behrens, et al.
Medical Microbiology and Immunology
|
April 14, 2010
Glycyrrhizin inhibits highly pathogenic H5N1 influenza A virus-induced pro-inflammatory cytokine and chemokine expression in human macrophages
Martin Michaelis, Janina Geiler, Patrizia Naczk, et al.
Journal of Medicinal Chemistry
|
February 3, 2006
Design and synthesis of dipeptidyl glutaminyl fluoromethyl ketones as potent severe acute respiratory syndrome coronovirus (SARS-CoV) inhibitors
Han-Zhong Zhang, Hong Zhang, William Kemnitzer, et al.
Journal of Clinical Microbiology
|
September 15, 2007
Novel approach for genotyping varicella-zoster virus strains from Germany
Jonas Schmidt-Chanasit, Martin Stürmer, Anke Hahn, et al.
Medical Microbiology and Immunology
|
September 19, 2003
Thrombin induces Sp1-mediated antiviral effects in cytomegalovirus-infected human retinal pigment epithelial cells
Martin Scholz, Jens-Uwe Vogel, Gerold Höver, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
June 30, 2009
Measurements of HCV neutralizing antibodies and of HCV-specific CD4+ and CD8+ cells using hepatitis C virus pseudo-particles (HCVpp)
Annemarie Berger, Tsanan Giroglou, Anke Leutz, et al.
Cancer Research
|
January 17, 2009
Reversal of P-glycoprotein-mediated multidrug resistance by the murine double minute 2 antagonist nutlin-3
Martin Michaelis, Florian Rothweiler, Denise Klassert, et al.
Sexually Transmitted Diseases
|
June 10, 2010
Prevalence- and gender-specific immune response to opportunistic infections in HIV-infected patients in Lesotho
Holger F Rabenau, Tessa Lennemann, Claudia Kircher, et al.
Page
of 12